Emergence of Acquired HIV Drug Resistance Among Individuals Receiving Dolutegravir-Based Antiretroviral Therapy in Uganda: A National Laboratory-Based Survey 2023 - Poll - MDSpire

Emergence of Acquired HIV Drug Resistance Among Individuals Receiving Dolutegravir-Based Antiretroviral Therapy in Uganda: A National Laboratory-Based Survey 2023

  • By

  • Juliet Nkugwa Asio

  • Christine Watera

  • Grace Namayanja

  • Juliana de Fatima da Silva

  • Sherri Pals

  • Deogratius Ssemwanga

  • Grace Sanyu

  • Maria Nannyonjo

  • Usher Kabuga Kaganda

  • Ronald Busobozi

  • Hellen Nansumba

  • Miriam Nabukenya

  • Alisen Ayitewala

  • Mina Ssali

  • Cordelia Katureebe

  • Eleanor Namusoke Magongo

  • Hudson Balidawa

  • Esther Nazziwa

  • Jonathan Ntale

  • Elliot Raizes

  • Du-Ping Zheng

  • Clement Zeh

  • Stephanie Hackett

  • Mary Naluguza

  • Edward Katongole Mbidde

  • Pontiano Kaleebu

  • November 6, 2025

  • 0 min

Share

Original Source(s)

Emergence of Acquired HIV Drug Resistance Among Individuals Receiving Dolutegravir-Based Antiretroviral Therapy in Uganda: A National Laboratory-Based Survey 2023

  • by Juliet Nkugwa Asio, Christine Watera, Grace Namayanja, Juliana de Fatima da Silva, Sherri Pals, Deogratius Ssemwanga, Grace Sanyu, Maria Nannyonjo, Usher Kabuga Kaganda, Ronald Busobozi, Hellen Nansumba, Miriam Nabukenya, Alisen Ayitewala, Mina Ssali, Cordelia Katureebe, Eleanor Namusoke Magongo, Hudson Balidawa, Esther Nazziwa, Jonathan Ntale, Elliot Raizes, Du-Ping Zheng, Clement Zeh, Stephanie Hackett, Mary Naluguza, Edward Katongole Mbidde, Pontiano Kaleebu

  • November 6, 2025

Related Content

Comparison of the therapeutic performance of macrolide antibiotics on macrolide-resistant or macrolide-susceptible Mycoplasma pneumoniae pneumonia children

UTI Prophylaxis Raises Resistance Risk

Study finds more resistance on culture, no significant rise in severe infections

Mandatory Training Modules Deserve a Harder Look

A JAMA Viewpoint argues that 4 million physician-hours spent on compliance modules each year warrants institutional reassessment.